M. Ziemen

Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

Hannele Yki‐Järvinen, A. Dressler, M. Ziemen · Diabetes Care · 2000 · 580 citations · Full text

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1)

Matthew C. Riddle, Geremia B. Bolli, M. Ziemen et al. · Diabetes Care · 2014 · 359 citations

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin‐naïve people with type 2 diabetes on oral glucose‐lowering drugs: a randomized controlled trial (EDITION 3)

Geremia B. Bolli, Matthew C. Riddle, Richard M. Bergenstal et al. · Diabetes Obesity and Metabolism · 2015 · 297 citations · Full text

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Oral Agents and Basal Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 2)

Hannele Yki‐Järvinen, Richard M. Bergenstal, M. Ziemen et al. · Diabetes Care · 2014 · 274 citations

Metabolic Syndrome, Diabetes Management, Basal Insulin +15

New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)

Philip Home, Richard M. Bergenstal, Geremia B. Bolli et al. · Diabetes Care · 2015 · 219 citations · Full text